Pharming Group N.V. (PHAR) EBITDA (2009 - 2026)
Pharming Group N.V. (PHAR) EBITDA from Mar 31, 2009 to Mar 31, 2026. The TTM Pharming Group N.V. (PHAR) EBITDA is $44M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Pharming Group N.V. (PHAR) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +331.29% |
| 3 Years TTM | +22.77% |
| 5 Years TTM | -13.01% |
Annual EBITDA change of Pharming Group N.V. (PHAR)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $1.06M | -96.95% |
| 2025 | $35M | +105.92% |
| 2024 | $17M | +70.95% |
| 2023 | $9.88M | -70.53% |
| 2022 | $34M | -39.37% |
| 2021 | $55M | -5.23% |
| 2020 | $58M | -18.35% |
| 2019 | $71M | +70.63% |
| 2018 | $42M | +65.73% |
| 2017 | $25M | -282.06% |
| 2016 | -$14M | +12.48% |
| 2015 | -$12M | -468.36% |
| 2014 | $3.35M | -154.83% |
| 2013 | -$6.11M | -49.04% |
| 2012 | -$12M | -36.86% |
| 2011 | -$19M | -19.53% |
| 2010 | -$24M | +8.51% |
| 2009 | -$22M | -10.35% |
| 2008 | -$24M | +12.11% |
| 2007 | -$22M | +2.22% |
| 2006 | -$21M | N/A |
Comparison Pharming Group N.V. (PHAR) five years EBITDA CAGR with competitors
Pharming Group N.V. (PHAR) five years EBITDA CAGR is -12.44%.